These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38399533)

  • 1. The Benefit of Hydrogen Gas as an Adjunctive Therapy for Chronic Obstructive Pulmonary Disease.
    Liu SF; Li CL; Lee HC; Chang HC; Liu JF; Kuo HC
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399533
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.
    Ohno T; Wada S; Hanada S; Sawaguchi H; Muraki M; Tohda Y
    Int J Chron Obstruct Pulmon Dis; 2014; 9():107-14. PubMed ID: 24489464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase.
    Vulpi MR; Liotino V; Dragonieri S; Buonamico E; Dimitri M; Capozzolo A; Resta E; Lozupone M; Panza F; Resta O
    Expert Rev Respir Med; 2020 Jun; 14(6):637-643. PubMed ID: 32249627
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy.
    Moretz C; Hahn B; White J; Goolsby Hunter A; Essoi B; Elliott C; Ray R
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2715-2725. PubMed ID: 33149569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Unsupervised Home-Based Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease.
    Lee JH; Lee HY; Jang Y; Lee JS; Oh YM; Lee SD; Lee SW
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2297-2305. PubMed ID: 33061347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis.
    Greulich T; Koczulla AR; Nell C; Kehr K; Vogelmeier CF; Stojanovic D; Wittmann M; Schultz K
    Respiration; 2015; 90(4):287-92. PubMed ID: 26340440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of the high-frequency chest wall oscillation vs intrapulmonary percussive ventilation in patients with severe COPD.
    Nicolini A; Grecchi B; Ferrari-Bravo M; Barlascini C
    Int J Chron Obstruct Pulmon Dis; 2018; 13():617-625. PubMed ID: 29497290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between pulmonary quantitative CT measurement indicators and respiratory symptoms in patients with chronic obstructive pulmonary disease in stable stage].
    Wang YX; Sun TY; Li YM; Zhang M; Wang GX; Chen QH; Guo YF
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(38):3017-3025. PubMed ID: 37813652
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.
    Miravitlles M; Koblizek V; Esquinas C; Milenkovic B; Barczyk A; Tkacova R; Somfay A; Zykov K; Tudoric N; Kostov K; Zbozinkova Z; Svoboda M; Sorli J; Krams A; Valipour A
    Respir Med; 2019 Apr; 150():141-148. PubMed ID: 30961941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Karayama M; Mori K; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Respir Med; 2019 Jan; 146():76-80. PubMed ID: 30665522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.